Home > News & Updates > AptaBind

AptaBind: Enabling Improved Protein Purification with Aptamer-Mediated Affinity Chromatography (AMAC)

8 February 2017
 Aptamer Technology Platform

Aptamers (short, synthetic DNA- or RNA-based molecules) are developed at Aptamer Group under strict laboratory conditions utilising our automated high-throughput selection platform. Aptamers have flexible, sequence specific structures that can form complimentary surfaces to all or part of their target. This structural synergy facilitates strong electrostatic, hydrogen bonding or stacking interactions […]

Aptamer Group launches new drug purification system ‘AptaBind’

19 April 2016
Aptamer Group Launch Aptabind!
Biological therapeutics have become highly popular in the fight against a range of diseases including cardiovascular disease, cancer and degenerative neurological conditions. They often rely on production of proteins inside biological systems including bacterial and fungal cells, meaning that purification of the proteins is essential to obtain a highly purified […]